Martin Wilson sold $128K of Rocket Pharmaceuticals stock
By AlphaYouPublished Form 4
Wilson Martin
Reporting filer
Martin Wilson reported selling 53,389 shares of Rocket Pharmaceuticals, Inc. for about $128K ($2.39 a share on average). Form 4 filed Nov 9, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 9, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Wilson Martin | 2026-11-05 | S | Sale | 53389 | 2.394 | 545,100 | 4 days | Filed terms
|
Common Stock
- Owner
- Wilson Martin
- Date
- 2026-11-05
- Code
- S
- Action
- Sale
- Quantity
- 53389
- Price
- 2.394
- Following holdings
- 545,100
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- id: F1
- transaction Date: 2026-11-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F2
- transaction Shares: 53389
- transaction Price Per Share: 2.394
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 545100
- id: F1
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Wilson Martin: General Counsel.
- F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Original sources
Prepared automatically from public filing data. Report a correction.